AIM: aimimmuno.com P/S multiplikatori
AIM ImmunoTech (AIM) aksiyalarining tebranishlari saraton va viruslarga qarshi kurashishda Ampligen RNA terapiyasining eksklyuzivligidan kelib chiqadi. Kompaniyaning sotuvlarga nisbatan narx koeffitsiyenti bozor talabini vizuallashtiradi, bunda 60.40 joriy ko'rsatkichni ifodalaydi. Barqarorlik grantlar va klinik sinovlar natijalariga bog'liq bo'lsa-da, yagona mahsulotga va tashqi moliyalashtirishga kritik darajada bog'liqlik biznes modeli uchun sezilarli xatarlarni yuzaga keltiradi.
AIM ImmunoTech (AIM) kompaniyasining tahliliy kesimlari
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati AIM ImmunoTech|AIM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti aimimmuno.com|AIM - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati AIM ImmunoTech|AIM - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari AIM ImmunoTech|Tezkor likvidlik koeffitsiyenti aimimmuno.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
AIM - Kompaniyaning sof foydasi|Sof foyda prognozi AIM ImmunoTech|AIM - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati AIM ImmunoTech, Inc.|AIM - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti AIM ImmunoTech|AIM - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda AIM ImmunoTech|AIM - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi aimimmuno.com|AIM - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi AIM ImmunoTech
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning fundamental tahlili:AIM (AIM ImmunoTech, Inc.)
P/S koeffitsiyenti bir dollarlik daromadning bozor qiymatini belgilab, bozor kapitalizatsiyasi va sotuvlardan kelib tushadigan haqiqiy pul oqimlari o'rtasidagi farqni aks ettiradi. Joriy P/S nisbatini tahlil qilish orqali investor AIM ImmunoTech biofarmatsevtika ishlanmalarining monetizatsiya samaradorligini, jumladan, laboratoriya ESG optimizatsiyasi va etika standartlarining biznesning bozor jozibadorligiga hamda uning fundamental qiymati o'sish sur'atiga ta'sirini baholaydi.
AIM ImmunoTech raqobatchilari
ARGX - Sotuvga nisbatan narx|P/S multiplikatori BNTX (BioNTech)|P/S multiplikatori Abivax Pharma ABVX|ADMA Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti Protagonist Corp PTGX|Immunovant, Inc. (IMVT) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati kiniksa.com|Kapitalizatsiyaning daromadga nisbati GRFS|ADPT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori CLDX|Narx/daromad koeffitsiyenti Aurinia Corp|Narxning daromadga nisbati BioCryst BCRX|VERA - Kapitalizatsiyaning daromadga nisbati|DNTH - Narxning daromadga nisbati|Pharvaris NV (PHVS) - Kapitalizatsiyaning daromadga nisbati|ABCL (AbCellera Biologics Inc) - Kapitalizatsiyaning daromadga nisbati|Tourmaline (TRML) - P/S multiplikatori|Narxning daromadga nisbati Precigen, Inc.|Kapitalizatsiya va daromad nisbati PHAR (pharming.com)|Narxning daromadga nisbati Nektar Therapeutics Inc. (NKTR)|UPB - Sotuvga nisbatan narx|Zenas Biopharma, Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati IMNM (Immunome Bio)|Gossamer Bio, Inc. - P/S multiplikatori|Sotuvga nisbatan narx kalvista.com|SEPN: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pieris Pharma|SVRA (Savara Corp) - P/S multiplikatori|RIGL: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ANAB|P/S multiplikatori astriatx.com (ATXS)|P/S multiplikatori ENGN (enGene)|Narx/daromad koeffitsiyenti RAPT Therapeutics Inc. (RAPT)|JBIO - Narxning daromadga nisbati|Aclaris Therapeutics, Inc (ACRS) - Kapitalizatsiyaning daromadga nisbati|Kyverna Therapeutics (KYTX) - Narxning daromadga nisbati|Narxning sotuvga nisbati TLSA (tizianalifesciences.com)|CABA (Cabaletta Bio) - P/S multiplikatori|VTYX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori THTX|P/S multiplikatori Avalo Therapeutics Inc (AVTX)|Narxning daromadga nisbati Eledon Pharmaceuticals ELDN|Bozor kapitallashuvining daromadga nisbati AGEN|CLYM - Narxning daromadga nisbati|Zura Bio Ltd (ZURA) - Kapitalizatsiyaning daromadga nisbati|ATYR: P/S multiplikatori|Adagene Inc. (ADAG) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati IMA|STTK: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EQ|Narx/daromad koeffitsiyenti connectbiopharm.com|Narxning daromadga nisbati Immunic IMUX|ATRA - Kapitalizatsiyaning daromadga nisbati|IFRX - Narxning daromadga nisbati|x4pharma.com (XFOR) - Kapitalizatsiyaning daromadga nisbati|ACET (adicetbio.com) - Kapitalizatsiyaning daromadga nisbati|Celularity (CELU) - P/S multiplikatori|Narxning daromadga nisbati INmune Bio Corp|Kapitalizatsiya va daromad nisbati BRNS (Barinthus Biotherapeutics Corp)|P/S multiplikatori KZR|SABS - Sotuvga nisbatan narx|P/S multiplikatori AKTX (Akari Therapeutics Plc)|P/S multiplikatori Enlivex Therapeutics Ltd ENLV|Q32 Bio Corp - P/S multiplikatori|Narx/daromad koeffitsiyenti GeoVax Corp GOVX|Edesa Biotech, Inc. (EDSA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati ibioinc.com|Kapitalizatsiyaning daromadga nisbati CARM|XTLB: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BOLT|Narx/daromad koeffitsiyenti hcwbiologics.com|Narxning daromadga nisbati Aptevo Therapeutics Inc. APVO|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI - Narxning daromadga nisbati|XORTX Therapeutics Inc (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (ReShape Lifesciences) - Kapitalizatsiyaning daromadga nisbati|Revelation Biosciences Corp (REVB) - P/S multiplikatori|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiya va daromad nisbati SCNI (scinai.com)|Narxning daromadga nisbati CalciMedica, Inc. (CALI)|AFMD - Sotuvga nisbatan narx|Allakos - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati HOOK (HOOKIPA Pharma, Inc.)|IGM Bio - P/S multiplikatori|Sotuvga nisbatan narx iteostherapeutics.com|OCEA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati TC BioPharm (Holdings) Plc|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
